GL1X · GenesisL1 explorer

Research workbench

Complex of UNG2 and a fragment-based designed inhibitor

Analyse Complex of UNG2 and a fragment-based designed inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3FCI
Type
protein
Length
223 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Uracil-DNA glycosylase
EC
3.2.2.-
UniProt
P13051
Ligands
3FI, NA, SCN
Pockets
1 · best druggability 0.52

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 11% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUracil-DNA glycosylase (EC 3.2.2.-)protein22339% helix, 11% strandP13051

Ligands and binding sites

  • 3FI · 3-{(E)-[(3-{[(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl]amino}propoxy)imino]methyl}benzoic acid · ligand · chains A
  • NA · Sodium ion · metal · chains A
  • SCN · Thiocyanate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11660.520.79363FI

Compared structures

  • 3FCI · Complex of UNG2 and a fragment-based designed inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P13051 · AlphaFold monomer V2.0 prediction for uracil-DNA glycosylase (P13051) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.